NASDAQ:ZY - Zymergen Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $6.75
  • Forecasted Upside: 396.32 %
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.36
▲ +0.16 (13.33%)

This chart shows the closing price for ZY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Zymergen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZY

Analyst Price Target is $6.75
▲ +396.32% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $6.75, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 396.32% upside from the last price of $1.36.

This chart shows the closing price for ZY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Zymergen.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/13/2022The Goldman Sachs GroupLower Price TargetNeutral$6.00 ➝ $4.00Medium
3/24/2022UBS GroupLower Price TargetNeutral$13.00 ➝ $4.00Medium
3/24/2022The Goldman Sachs GroupLower Price TargetNeutral$10.50 ➝ $6.00Medium
3/9/2022William BlairReiterated RatingMarket PerformMedium
1/12/2022HSBCUpgradeReduce ➝ Hold$6.50Low
11/4/2021The Goldman Sachs GroupLower Price TargetNeutral$12.00 ➝ $10.50Medium
10/15/2021CowenInitiated CoverageMarket PerformHigh
9/27/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.00Medium
8/31/2021UBS GroupDowngradeBuy ➝ Neutral$56.00 ➝ $13.00Medium
8/4/2021CitigroupDowngradeBuy ➝ Underperform$43.00 ➝ $7.00N/A
8/4/2021Bank of AmericaDowngradeBuy ➝ Underperform$43.00 ➝ $7.00N/A
8/4/2021HSBCDowngradeHold ➝ Reduce$8.00N/A
8/4/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$12.00N/A
8/4/2021William BlairDowngradeOutperform ➝ Market PerformN/A
8/4/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00 ➝ $12.00N/A
8/4/2021CowenDowngradeOutperform ➝ Market PerformN/A
7/6/2021HSBCInitiated CoverageHold$42.00Medium
6/29/2021William BlairInitiated CoverageOutperformHigh
5/17/2021CowenInitiated CoverageOutperformHigh
5/17/2021Bank of AmericaInitiated CoverageBuy$43.00High
5/17/2021JPMorgan Chase & Co.Initiated CoverageOverweight$40.00High
5/17/2021The Goldman Sachs GroupInitiated CoverageBuy$55.00High
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/7/2021
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/6/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/5/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/7/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
4/6/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/6/2022
  • 2 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
6/5/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
7/5/2022

Current Sentiment

  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Zymergen logo
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.
Read More

Today's Range

Now: $1.36
Low: $1.15
High: $1.36

50 Day Range

MA: $1.46
Low: $1.12
High: $1.85

52 Week Range

Now: $1.36
Low: $1.10
High: $41.93

Volume

1,198,904 shs

Average Volume

1,814,598 shs

Market Capitalization

$140.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Zymergen?

The following Wall Street sell-side analysts have issued reports on Zymergen in the last year: Bank of America Co., Citigroup Inc., Cowen Inc, HSBC Holdings plc, JPMorgan Chase & Co., The Goldman Sachs Group, Inc., UBS Group AG, and William Blair.
View the latest analyst ratings for ZY.

What is the current price target for Zymergen?

0 Wall Street analysts have set twelve-month price targets for Zymergen in the last year. Their average twelve-month price target is $6.75, suggesting a possible upside of 396.3%.
View the latest price targets for ZY.

What is the current consensus analyst rating for Zymergen?

Zymergen currently has 3 sell ratings and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ZY, but not buy more shares or sell existing shares.
View the latest ratings for ZY.

How do I contact Zymergen's investor relations team?

The company's listed phone number is 415-801-8073 and its investor relations email address is [email protected] The official website for Zymergen is www.zymergen.com. Learn More about contacing Zymergen investor relations.